GENBNasdaqPharmaceutical Preparations

Generate Biomedicines, Inc. (GENB) earnings date, market-implied expected move, and options open interest by expiry

13.84

pre 14.00 +1.08%

Pre-market08:55 ETdelayed

Open14.20Volume745,410Mkt cap$1.7B

Day13.91 – 14.3023%52-wk11.00 – 22.6726%

GENB

Generate Biomedicines, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

—

Calendar

Next report

Last report

−4.14%

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

14hAMGN · customerAmgen reports quarterly net income $3,864 million, diluted EPS $7.08
1dNVS · customerBioArctic collaborator Novartis terminates agreement

News

Largest filed tie

13F top-10 QoQ

+0.24%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

86 managers

Top fund weight

0.01%

GENB weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Generate Biomedicines (GENB). No implied move.

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 6 '26confirmed—▼−4.14%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−4.14%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 4 expiries · Nov 3 close

0.14OI · 4 expiries · Nov 3 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

280+375%Nov 2016d1,977+18%

34—Dec 1844d0.10331—0.10

200%Jan 1572d0.04465+72%0.04

81+5%Apr 16163d0.12693+542%0.12

ExpiryPutsCallsP/C

Nov 2016d280+375%1,977+18%0.14

Dec 1844d34—331—0.10

Jan 1572d200%465+72%0.04

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−1065.17%as filednet margin · revenue −12.60% QoQ · −37.67% YoY

Revenue$6M−12.60%

Gross profit$6M100.00%−12.60%

Operating income−$72M−1134.21%−11.70%

Pre-tax income−$67M−8.94%

Net income−$67M−1065.17%−8.98%

Cost of revenue$0—

Operating expenses$78M+9.24%

Tax$53,000+89.29%

Other income$4M+81.86%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 08:45 ET

Intraday

Event sensitivity

GDP ×1.31· ±5.1% vs ±3.9% · 7 releases

eventrelease day|move|up · n×base

GDPgross domestic product±5.1%4 of 7×1.31

PCEpersonal income & outlays±5.1%4 of 7×1.31

NFPjobs report±4.7%4 of 7×1.21

CPIconsumer prices±3.0%5 of 8×0.77

PPIproducer prices±2.3%3 of 8×0.59

Bar = avg |move| to ±6% · tick = ±3.9% avg day · ×base = |move| ÷ ±3.9% · min 6 releases

Earnings history

EPS -0.52 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	-0.52	—
Q1 FY26	—	-1.07	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod